Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2010
11/18/2010US20100291159 Film coatings containing fine particle size detackifiers and substrates coated therewith
11/18/2010US20100291116 Microparticle comprising cross-linked polymer
11/18/2010US20100291021 Aliphatic prodrug linker
11/18/2010US20100291006 Natural Preservatives and Antimicrobial Agents
11/18/2010US20100290983 Compositions and Methods for Drug Delivery
11/18/2010CA2764864A1 Solid cosmetic composition with structurant and electrolyte solution
11/18/2010CA2761937A1 Hyaluronic acid (ha) injection vehicle
11/18/2010CA2761801A1 Compositions and methods for drug delivery
11/18/2010CA2761739A1 Oil-in-water emulsion of mometasone and propylene glycol
11/18/2010CA2761605A1 Use of lipid conjugates in the treatment of diseases associated with vasculature
11/18/2010CA2761590A1 Lipid-polymer conjugates, their preparation and uses thereof
11/18/2010CA2761455A1 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
11/18/2010CA2761438A1 Compositions and methods for treating hematologic cancers targeting the sirp-.alpha.-cd47 interaction
11/18/2010CA2759546A1 A method and composition for the control of ectoparasites
11/17/2010EP2251694A1 Kit for detecting cancer cells metastasizing into sentinel lymph node
11/17/2010EP2251039A2 Oligo double-stranded rna inhibiting the expression of bcl-2 and pharmaceutical composition containing the same
11/17/2010EP2251038A1 Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
11/17/2010EP2251033A1 Pharmaceutical formulations comprising paraoxonase
11/17/2010EP2251012A1 Tablet having improved elution properties
11/17/2010EP2251011A1 Solid preparation for oral administration
11/17/2010EP2251006A1 Microparticles and pharmaceutical compositions thereof
11/17/2010EP2251005A1 Orally disintegrating tablets
11/17/2010EP2251003A2 Ophthalmic Compositions for the Re-epithelialization, Healing and Disinfection of the Eye Tissues
11/17/2010EP2250504A2 Use of fsh receptor ligands for diagnosis and therapy of cancer
11/17/2010EP2250278A2 Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications
11/17/2010EP2249879A2 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
11/17/2010EP2249873A2 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids
11/17/2010EP2249872A1 Oligomer-diarylpiperazine conjugates
11/17/2010EP2249871A2 Opthalmic composition
11/17/2010EP2249870A2 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production
11/17/2010EP2249869A1 Liquid formulation of fsh
11/17/2010EP2249853A1 Ester-based peptide prodrugs
11/17/2010EP2249811A1 Pharmaceutical dosage form
11/17/2010EP2249809A1 Powdered protein compositions and methods of making same
11/17/2010EP2249804A2 Implantable products comprising nanoparticles
11/17/2010EP2249802A2 Composition and method for assisting swallowing
11/17/2010EP2249799A2 Freezable lubricant
11/17/2010EP1545597B1 Immunostimulatory compositions and methods of stimulating an immune response
11/17/2010EP1480616B1 Aerosol formulations of diisobutyryl apomorphine
11/17/2010EP1310517B2 Lactic acid polymer and process for producing the same
11/17/2010EP1280486B1 Minimizing adverse experience associated with oxybutynin therapy
11/17/2010CN1927400B Biomagnetism nano target anti-cancer drug and its preparation
11/17/2010CN1882523B Novel phenol derivative, and anti-trypanosomiasis medicine with the phenol derivative as effective ingredient
11/17/2010CN101889023A Purification of PEGylated polypeptides
11/17/2010CN101888836A Oral drug delivery system based on poly dl- lactide-co-glycolide (plg) nano particles used for azole, moxifloxacin and rifampicin
11/17/2010CN101888832A Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
11/17/2010CN101888830A 透皮递送系统 Transdermal delivery systems
11/17/2010CN101885906A Degradable biological hydrogel and preparation method thereof
11/17/2010CN101884818A Suction administration system
11/17/2010CN101884791A Latrozole co-ground material, preparation method thereof and medicament composition having same
11/17/2010CN101884752A Chinese medicinal preparation for navel plaster and preparation method thereof
11/17/2010CN101884683A Uncaria slow-release pill preparation and preparation method thereof
11/17/2010CN101884668A Composition for preventing and treating allergic rhinitis and preparation method thereof
11/17/2010CN101884667A Xiangdan medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof
11/17/2010CN101884658A Compound angelica medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof
11/17/2010CN101884642A Compound emulsifiable paste for treating acne and preparation method thereof
11/17/2010CN101884639A Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
11/17/2010CN101884633A Beta-lactam antibiotic solution and preparation method thereof
11/17/2010CN101884630A Taltirelin solid preparation
11/17/2010CN101884627A Pioglitazone hydrochloride gastric residential sustained release tablet and preparation method thereof
11/17/2010CN101884626A Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
11/17/2010CN101884624A Long-acting benserazide sustained release microsphere composition and preparation method thereof
11/17/2010CN101884623A Levodopa methyl ester slow-release microsphere composition and preparation method thereof
11/17/2010CN101884622A Benserazide sustained-release microspherical composition and preparation method thereof
11/17/2010CN101884620A Activated carbon granule of load quantum dots as well as preparation method and application thereof
11/17/2010CN101884619A Zolpidem tartrate controlled-release pellet and preparation method thereof
11/17/2010CN101884618A Long-circulating paclitaxel nanoparticles and preparation method thereof
11/17/2010CN101884617A Method for preparing proanthocyanidins liposomes
11/17/2010CN101884616A Docetaxel long-circulating liposome and preparation method thereof
11/17/2010CN101884615A Bulleyaconitine A liposome and preparation method thereof
11/17/2010CN101884614A Preparation of brain targeting chuanxiongzine oral oil package oil nano-emulsion
11/17/2010CN101884613A Moxifloxacinhydrochloride sodium chloride injection, preparation method thereof and use thereof
11/17/2010CN101884612A Preparation method of large volume ribavirin injection
11/17/2010CN101584865B Corn core carrier modifying method
11/17/2010CN101496903B Coating solution of medicament for reducing stimulation of medicament to stomach
11/17/2010CN101481424B Ultra-fine microcrystalline cellulose and preparation thereof
11/17/2010CN101337072B Preparation method of sustained and controlled release medicine material
11/17/2010CN101320607B Preparation method of ferroferric oxide/multi-wall carbon nano-tube magnetic nanometer composite material
11/17/2010CN101288648B Easy-to-administrate oxiracetam granular formulation and preparation method
11/17/2010CN101249079B Andrographolide succinic acid half-ester natrium potassium salt and preparations
11/17/2010CN101244059B Compound silibinin injection, preparation method and application thereof
11/17/2010CN101224205B Composition of atorvastatin and levorotatory amlodipine and preparing method thereof
11/17/2010CN101214246B Palmatine nano particle preparations and preparation method thereof
11/17/2010CN101199511B Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic
11/17/2010CN101180052B Film coated preparation containing dextrose
11/16/2010US7834138 Segmented polymers and their conjugates
11/16/2010US7834088 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
11/16/2010US7834060 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
11/16/2010US7833992 biological conjugates used for drug delivery; side effect reduction
11/16/2010US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target
11/16/2010US7833972 Proteins and use thereof
11/16/2010US7833546 Pharmaceutical dosage form and method for the production thereof
11/16/2010US7833543 Sustained release of active materials; storage stability
11/16/2010US7833542 Method and composition for the treatment of scars
11/16/2010US7833538 using an immunostimulatory dinucleotide of formula CpG*, wherein C is a natural or non-natural pyrimidine nucleoside and G* is 7-deazaguanosine; for treating autoimmune disorders, such as autoimmune asthma; allergies
11/16/2010US7833535 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/16/2010US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon
11/16/2010US7832351 Actuation indicator for a dispensing device
11/16/2010CA2532714C Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 1712